New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients
Open Access
- 7 July 2009
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 3 (7), e484
- https://doi.org/10.1371/journal.pntd.0000484
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Rational Modification of a Candidate Cancer Drug for Use Against Chagas DiseaseJournal of Medicinal Chemistry, 2009
- Neglected Disease Research and Development: How Much Are We Really Spending?PLoS Medicine, 2009
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and EliminationPLoS Neglected Tropical Diseases, 2008
- The Challenges of Chagas Disease— Grim Outlook or Glimmer of Hope?PLoS Medicine, 2007
- Neglected Diseases and Poverty in “The Other America”: The Greatest Health Disparity in the United States?PLoS Neglected Tropical Diseases, 2007
- Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease FrameworkPLoS Neglected Tropical Diseases, 2007
- A Cysteine Protease Inhibitor Cures Chagas' Disease in an Immunodeficient-Mouse Model of InfectionAntimicrobial Agents and Chemotherapy, 2007
- Kinetic Characterization of Squalene Synthase fromTrypanosoma cruzi: Selective Inhibition by Quinuclidine DerivativesAntimicrobial Agents and Chemotherapy, 2007
- The Genome Sequence of Trypanosoma cruzi , Etiologic Agent of Chagas DiseaseScience, 2005
- New Drugs for Neglected Diseases: From Pipeline to PatientsPLoS Medicine, 2004